Skip to content

Quality of life in patients with postsurgical hypoparathyroidism

Quality of life and burden of disease in patients with hypoparathyroidism after thyroid surgery in the Southwestern region of the Netherlands.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28953
Enrollment
225
Registered
2019-01-31
Start date
2019-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parathyroid disease

Interventions

None listed

Sponsors

Erasmus Medical Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Patients who are aged 18 years or older at the time of inclusion - Patients who gave informed consent - Both cases and controls underwent (completion) thyroidectomy - Cases have persisting hypoparathyroidism according to the previously mentioned definition and controls do not

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Patients who are not able to provide written informed consent - No adequate understanding of the Dutch language - Parathyroid disease or parathyroid surgery

Design outcomes

Primary

MeasureTime frame
The primary objective of this study are: - To assess the physical quality of life in patients with hypoparathyroidism as measured by the SF-36 questionnaire. - To determine the Thyroid-Related quality of life in patients with hypoparathyrodism - To determine the cognitive and functional outcomes in patients with hypoparathyrodism - To determine the burden of disease in patients with hypoparathyroidism

Secondary

MeasureTime frame
The secondary objective of this study is to the determine the burden of disease in patients with hypoparathyroidism, attributed to hypoparathyroidism and hypoparathyroidism treatment by measuring medication use, the absence of work/return to work, extra hospital visits, comorbidities, hypoparathyroidism related laboratory parameters.

Contacts

Public ContactTessa M. van Ginhoven

Erasmus MC

t.vanginhoven@erasmusmc.nl0107040380

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)